NON-SMALL CELL LUNG CANCERS
Clinical trials for NON-SMALL CELL LUNG CANCERS explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCERS trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer combo trial ends before it begins: only one patient enrolled
Disease control TerminatedThis early-phase trial aimed to test the safety of combining two drugs, adagrasib and olaparib, in people with advanced solid tumors that have a specific genetic change called KRAS G12C. The study planned to include patients with certain breast, ovarian, pancreatic, and lung canc…
Matched conditions: NON-SMALL CELL LUNG CANCERS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Promising combo for rare cancer mutation stalls as study ends early
Disease control TerminatedThis early-phase study tested a new drug called PRT3789 combined with the immunotherapy pembrolizumab (Keytruda) in people with advanced solid tumors that have a SMARCA4 gene mutation. The goal was to see if the combination was safe and could shrink tumors. However, the study was…
Matched conditions: NON-SMALL CELL LUNG CANCERS
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC